{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:18Z","timestamp":1790622318083,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbr.2013.01.035","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T16:01:49Z","timestamp":1359993709000},"page":"15-28","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats"],"prefix":"10.1016","volume":"244","author":[{"given":"N.M.W.J.","family":"de Bruin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Drimmelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Elk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Middelveld-van de","family":"Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Schwienbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.01.035_bib0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"May","key":"10.1016\/j.bbr.2013.01.035_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2009.02.004","article-title":"Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia","volume":"122","author":"Young","year":"2009","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.035_bib0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/appi.ajp.2008.08060806","article-title":"Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)","volume":"166","author":"Davidson","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2010.11.008","article-title":"The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study","volume":"126","author":"Kern","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","article-title":"Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria","volume":"56","author":"Green","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2012.06.006","article-title":"From antipsychotic to anti-schizophrenia drugs: role of animal models","volume":"33","author":"Geyer","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.bbr.2013.01.035_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.biopsych.2009.05.016","article-title":"Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome","volume":"66","author":"Leeson","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(98)00156-X","article-title":"Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage","volume":"37","author":"Pantelis","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2009.03.039","article-title":"Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory","volume":"112","author":"Pantelis","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0055","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/0735-7044.113.1.32","article-title":"Involvement of rodent prefrontal cortex subregions in strategy switching","volume":"113","author":"Ragozzino","year":"1999","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/taap.2001.9199","article-title":"Spatial reversal learning in Aroclor 1254-exposed rats: sex-specific deficits in associative ability and inhibitory control","volume":"174","author":"Widholm","year":"2001","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881103017001700","article-title":"The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat","volume":"17","author":"Abdul-Monim","year":"2003","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2006.01.019","article-title":"The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm","volume":"169","author":"Abdul-Monim","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00213-004-2058-5","article-title":"Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat","volume":"179","author":"Idris","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0085","first-page":"150","article-title":"5-HT6 receptor ligands and their antipsychotic potential, IV. Effects in models of CIAS (Cognitive Impairment Associated with Schizophrenia)","volume":"vol. 96","author":"Arnt","year":"2011"},{"key":"10.1016\/j.bbr.2013.01.035_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.035_bib0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-009-1702-5","article-title":"Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms","volume":"208","author":"Idris","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-008-1132-9","article-title":"Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat\u2014a back translational study","volume":"202","author":"Goetghebeur","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1301223","article-title":"Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia","volume":"32","author":"Featherstone","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1071-5","article-title":"Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats","volume":"198","author":"Egerton","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bbr.2013.01.035_bib0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2008.02.020","article-title":"Evaluation of a neurodevelopmental model of schizophrenia\u2014early postnatal PCP treatment in attentional set-shifting","volume":"190","author":"Broberg","year":"2008","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0893-133X(00)00174-3","article-title":"Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats","volume":"24","author":"Jentsch","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0269881107067097","article-title":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","volume":"21","author":"Abdul-Monim","year":"2007","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0135","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1097\/00001756-200312020-00018","article-title":"The NMDA-receptor antagonist MK-801 selectively disrupts reversal learning in rats","volume":"14","author":"Van der Meulen","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2013.01.035_bib0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1037\/a0022038","article-title":"A comparison of adult and adolescent rat behavior in operant learning, extinction, and behavioral inhibition paradigms","volume":"125","author":"Andrzejewski","year":"2011","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/0014-4886(63)90094-3","article-title":"Conditioning and extinction of a food-rewarded response after selective ablations of frontal cortex in rhesus monkeys","volume":"7","author":"Butter","year":"1963","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuroimage.2008.08.021","article-title":"Dissociable roles of medial orbitofrontal cortex in human operant extinction learning","volume":"43","author":"Finger","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.bbr.2013.01.035_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2007.02.005","article-title":"Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat","volume":"179","author":"Boulougouris","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0160","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1523\/JNEUROSCI.23-25-08771.2003","article-title":"Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex","volume":"23","author":"Chudasama","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbr.2003.09.019","article-title":"Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat","volume":"146","author":"McAlonan","year":"2003","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0170","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1523\/JNEUROSCI.20-13-05179.2000","article-title":"Changes in functional connectivity in orbitofrontal cortex and basolateral amygdala during learning and reversal training","volume":"20","author":"Schoenbaum","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1196\/annals.1401.013","article-title":"The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial striatum to behavioral flexibility","volume":"1121","author":"Ragozzino","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.035_bib0450","first-page":"151","article-title":"Extinction: behavioral mechanisms and their Implications","volume":"vol. 1","author":"Bouton","year":"2008"},{"key":"10.1016\/j.bbr.2013.01.035_bib0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1037\/a0024403","article-title":"Effects of d-cycloserine on the extinction of appetitive operant learning","volume":"125","author":"Vurbic","year":"2011","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/lm.78804","article-title":"Context and behavioral processes in extinction","volume":"11","author":"Bouton","year":"2004","journal-title":"Learning and Memory"},{"key":"10.1016\/j.bbr.2013.01.035_bib0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.npp.1301555","article-title":"Neural mechanisms of extinction learning and retrieval","volume":"33","author":"Quirk","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.biopsych.2008.09.017","article-title":"Extinction memory is impaired in schizophrenia","volume":"65","author":"Holt","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2010.05.043","article-title":"Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat","volume":"214","author":"McLean","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5-HT6 receptors: a novel target for cognitive enhancement","volume":"108","author":"Mitchell","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.035_bib0220","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.npp.1301654","article-title":"Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics","volume":"33","author":"Rodefer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0455","first-page":"1","article-title":"Pharmacology of 5-HT6 receptors, Part II","volume":"vol. 96","author":"Borsini","year":"2011"},{"key":"10.1016\/j.bbr.2013.01.035_bib0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-005-2261-z","article-title":"5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats","volume":"181","author":"Hatcher","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0235","first-page":"642","article-title":"5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia","volume":"11","author":"Johnson","year":"2008","journal-title":"Current Opinion in Drug Discovery and Development"},{"key":"10.1016\/j.bbr.2013.01.035_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"European Journal of Pharmacolgy"},{"key":"10.1016\/j.bbr.2013.01.035_bib0245","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuropharm.2008.06.061","article-title":"An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function","volume":"55","author":"Fone","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-011-2518-7","article-title":"The effects of PRX-07034, a novel 5-HT(6) antagonist, on cognitive flexibility and working memory in rats","volume":"220","author":"Mohler","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bbr.2013.01.035_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coph.2011.01.004","article-title":"5-HT(6) receptor and cognition","volume":"11","author":"Codony","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nlm.2011.06.015","article-title":"Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats","volume":"96","author":"de Bruin","year":"2011","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.bbr.2013.01.035_bib0265","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(81)90086-8","article-title":"Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats","volume":"73","author":"Castellani","year":"1981","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0275","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pnpbp.2007.09.008","article-title":"Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study","volume":"32","author":"Kalinichev","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0280","first-page":"1393","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andin\u00e9","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.035_bib0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1300031","article-title":"Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs","volume":"28","author":"Cochran","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl.","key":"10.1016\/j.bbr.2013.01.035_bib0290","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1038\/bjp.2008.24","article-title":"Modelling prefrontal cortex deficits in schizophrenia: implications for treatment","volume":"153","author":"Pratt","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0295","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3649","article-title":"Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap","volume":"11","author":"Pratt","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.bbr.2013.01.035_bib0300","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1037\/0735-7044.120.5.1071","article-title":"NMDA receptor antagonism impairs reversal learning in developing rats","volume":"120","author":"Chadman","year":"2006","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-010-1945-1","article-title":"A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists","volume":"212","author":"Dix","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0310","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-009-1530-7","article-title":"Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for NMDA antagonist modelling of schizophrenia","volume":"205","author":"Gilmour","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0315","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.lfs.2005.09.018","article-title":"The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine","volume":"78","author":"Pechnick","year":"2006","journal-title":"Life Sciences"},{"key":"10.1016\/j.bbr.2013.01.035_bib0320","first-page":"887","article-title":"The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-d-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites","volume":"36","author":"Rothman","year":"1989","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0325","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050491","article-title":"The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs","volume":"135","author":"Mele","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001756-200001170-00034","article-title":"Effects of dizocilpine (MK-801) on noradrenaline, serotonin and dopamine release and uptake","volume":"11","author":"Callado","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2013.01.035_bib0335","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0340","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuropharm.2011.03.015","article-title":"NMDA receptors, cognition and schizophrenia \u2013 tsting the validity of the NMDA receptor hypofunction hypothesis","volume":"62","author":"Gilmour","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0345","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-010-1959-8","article-title":"Dopamine-mediated MK-801-induced elevation in food-based extinction responding in rats and associated changes in region-specific phosphorylated ERK","volume":"212","author":"Holahan","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0350","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbr.2011.11.044","article-title":"Comparison of the MK-801-induced appetitive extinction deficit with pressing for reward and associated pERK1\/2 staining in prefrontal cortex and nucleus accumbens","volume":"228","author":"Holahan","year":"2012","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0355","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.21-22-09009.2001","article-title":"Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory","volume":"21","author":"Santini","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.035_bib0360","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nlm.2004.04.004","article-title":"The influence of NMDA receptors in the dorsomedial striatum on response reversal learning","volume":"82","author":"Palencia","year":"2004","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.bbr.2013.01.035_bib0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00008877-200502000-00003","article-title":"Performance of male C57BL\/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment","volume":"16","author":"Podhorna","year":"2005","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0370","series-title":"Context and learning","first-page":"357","article-title":"Contextual stimulus effects of drugs and internal states","author":"Overton","year":"1985"},{"key":"10.1016\/j.bbr.2013.01.035_bib0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbr.2010.02.017","article-title":"Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats","volume":"210","author":"Casta\u00f1\u00e9","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.035_bib0380","first-page":"2","article-title":"Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?","author":"Keefe","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.bbr.2013.01.035_bib0385","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/schbul\/sbq038","article-title":"The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?","volume":"37","author":"Buchanan","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.bbr.2013.01.035_bib0460","first-page":"111","article-title":"Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement","volume":"vol. 96","author":"Di Chiara","year":"2011"},{"key":"10.1016\/j.bbr.2013.01.035_bib0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","article-title":"The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus","volume":"25","author":"Dawson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0400","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0361-9230(02)00967-X","article-title":"Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist","volume":"59","author":"Dawson","year":"2003","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.bbr.2013.01.035_bib0405","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2013.01.035_bib0410","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/jm021085c","article-title":"Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist","volume":"46","author":"Riemer","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bbr.2013.01.035_bib0415","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0420","first-page":"59","article-title":"5-HT6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bbr.2013.01.035_bib0465","first-page":"1","article-title":"The central role of 5-HT6 receptors in modulating brain neurochemistry","volume":"vol. 96","author":"Dawson","year":"2011"},{"key":"10.1016\/j.bbr.2013.01.035_bib0430","doi-asserted-by":"crossref","first-page":"S631","DOI":"10.1016\/j.jalz.2006.05.2128","article-title":"5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease","volume":"2","author":"Chuang","year":"2006","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.bbr.2013.01.035_bib0435","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.neuropharm.2008.03.012","article-title":"The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats","volume":"54","author":"Foley","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0440","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4419-1170-4_19","article-title":"NCAM in neuropsychiatric and neurodegenerative disorders","volume":"663","author":"Brennaman","year":"2010","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.bbr.2013.01.035_bib0445","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1073\/pnas.92.7.2785","article-title":"Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains","volume":"92","author":"Barbeau","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T08:09:56Z","timestamp":1644221396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":89,"alternative-id":["S0166432813000545"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.01.035","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}